IQS Is Awarded Multi-Year Contract by the FDA To Support ISO 17025

CLEVELAND, Dec. 5, 2006 -- IQS, the leading provider of Enterprise Quality and Compliance Management Software, has been awarded a multi-year contract by the FDA to expand the application of quality management principles across two major laboratory centers. Current use of IQS software at the Center for Biological Evaluation and Research (CBER) is being expanded and a new initiative will be supported in the Center for Drug Evaluation and Research (CDER).

IQS has been tasked to support the adoption of ISO 17025 at the two research centers. This project will provide the information management systems that will help parts of the FDA comply with ISO 17025 standards. The quality practices will assist in the measurement, recording and reporting of product performance data developed from the testing of products developed for sale by drug and biologics companies.

The contract provides for the expansion of the IQS Business System, as a hub for capturing, coordinating and communicating aspects of quality information used to support FDA regulatory functions. IQS, the manufacturer of the underlying Enterprise Quality and Compliance Management software, will provide process, implementation and training support for the roll-out at multiple laboratories.

About IQS

IQS is the industry leader in enterprise compliance and quality software solutions. IQS' software is used by over 20,000 users across automotive, medical devices, chemical, aerospace and FDA regulated manufacturers. Customers large and small, such as Baxter, Blackstone Medical, Bio Tissues, Volk Optical, PolyOne, Eaton, Bonne Belle and Dornier MedTech, use IQS to optimize traceability, supplier collaboration, regulatory compliance and overall quality management. Using IQS' out-of-the-box solution, customers are up and running in weeks, not years. IQS customers experience short payback times and bottom line returns on their investment. For more information, or an in-depth ROI model to understand your potential savings, visit www.iqs.com.